Navigation Links
STAAR Surgical To Present At Upcoming Investor Conferences
Date:5/21/2013

MONROVIA, Calif., May 21, 2013 /PRNewswire/ -- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced that it will participate in three upcoming investor conferences to review the Company's recent financial results and business developments with investors and interested parties.

STAAR Surgical will present at the 38th Annual Deutsche Bank 2013 Healthcare Conference in Boston at the Westin Waterfront Hotel on Wednesday, May 29, 2013 at 10:40 a.m. ET.  Barry G. Caldwell , President and CEO and Hans Blickensdoerfer, President, Europe, Middle East, Africa, will be presenting at the conference.

The Benchmark Company One-on-One Investor Conference will be held on Thursday, May 30, 2013 at the Pfister Hotel in Milwaukee, Wisconsin.  Barry Caldwell and Hans Blickensdoerfer will meet with interested investors in a series of one-on-one meetings.

The Company will also present at the Jefferies 2013 Global Healthcare Conference at the Grand Hyatt Hotel in New York on Thursday, June 6, 2013 at 2:00 p.m. ET.  Barry Caldwell and Sam Gesten , General Counsel, will be presenting at the conference.

STAAR will offer a live video webcast of its presentations at Deutsche Bank and Jefferies on the Company's website, www.staar.com, under Investor Information. An archived replay of these presentations will be available for 90 days following the event date, also at www.staar.com.  The Benchmark conference does not provide for companies to webcast the event.

About STAAR SurgicalSTAAR, which has been dedicated solely to ophthalmic surgery for over 25 years, designs, develops, manufactures and markets implantable lenses for the eye and delivery systems therefor. All of these lenses are foldable, which permits the surgeon to insert them through a small incision. STAAR's lens used in refractive surgery as an alternative to LASIK is called an Implantable Collamer® Lens or "ICL." A lens used to replace the natural lens after cataract surgery is called an intraocular lens or "IOL." Over 350,000 Visian ICLs have been implanted to date; to learn more about the ICL go to: www.visianinfo.com. STAAR has approximately 300 full time employees and markets lenses in over 60 countries. Headquartered in Monrovia, CA, it manufactures in the following locations: Nidau, Switzerland; Ichikawa City, Japan; Aliso Viejo, CA; and Monrovia, CA. For more information, please visit the Company's website at www.staar.com.CONTACT:

Investors

MediaEVC Group

EVC GroupDouglas Sherk, 415-652-9100

Amy Phillips, 412-327-9499 Leigh Salvo, 415-568-9348
'/>"/>

SOURCE STAAR Surgical Company
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. STAAR Surgical Reports Strong First Quarter 2013 Financial Results
2. STAAR Surgical Provides Preliminary First Quarter Revenue Results
3. STAAR Surgical Announces Fourth Quarter 2012 Results Release Date And Conference Call And Webcast
4. STAAR Surgical Reports Third Quarter 2012 Financial Results
5. STAAR Surgical Appoints Charles Slacik To Its Board Of Directors
6. STAAR Surgical Builds Leadership Team to Drive Growth Opportunities
7. STAAR Surgical Expands Footprint for Growth with Lease on Adjacent Building in Monrovia, California
8. STAAR Surgical To Present At The 32nd Annual Canaccord Growth Conference
9. STAAR Surgical Reports Second Quarter 2012 Financial Results
10. STAAR Surgical Provides Outlook On Second Quarter 2012 Financial Results
11. STAAR Surgical To Present At The Benchmark And Jefferies Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... OTTAWA, Ontario , June 27, 2016  VMS ... the Company,s Board will take whatever measures required to ... the Company,s stock which is currently listed on the ... S Wexler, Company Chairman and CEO, "We are seeing ... be difficult to understand, not only by the Company, ...
(Date:6/24/2016)... SAN FRANCISCO, Calif. , June 24, 2016 ... GBT ), a biopharmaceutical company developing novel therapeutics ... significant unmet needs, today announced the closing of ... shares of common stock, at the public offering ... shares in the offering were offered by GBT. ...
(Date:6/24/2016)... ALEXANDRIA, Va. , June 24, 2016 ... a set of recommendations that would allow ... information (HCEI) with entities that make formulary and coverage ... determine the "value" of new medicines. The ... that does not appear on the drug label, a ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... ... "With 30 hand-drawn hand gesture animations, FCPX users can easily customize each ... Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn pictures into hand ... select a ProHand generator and drag it above media or text in the Final ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has dedicated ... has implemented orthobiologic procedures as a method for treating his patients. The procedure ... doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published ... unfamiliar with. The article goes on to state that individuals are now more comfortable ... less common operations such as calf and cheek reduction. The Los Angeles area medical ...
(Date:6/24/2016)... ... 2016 , ... Marcy was in a crisis. Her son James, eight, was out of control. ... and physically. , “When something upset him, he couldn’t control his emotions,” remembers Marcy. ... rocks at my other children and say he was going to kill them. If ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. ... accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas of orthodontics, ... and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic ...
Breaking Medicine News(10 mins):